{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:51:19Z","timestamp":1772250679121,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T00:00:00Z","timestamp":1526601600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00246-018-1897-5","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T00:20:25Z","timestamp":1526602825000},"page":"1315-1322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Ambulatory Intravenous Inotropic Support and or Levosimendan in Pediatric and Congenital Heart Failure: Safety, Survival, Improvement, or Transplantation"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9088-9584","authenticated-orcid":false,"given":"Sotiria C.","family":"Apostolopoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George A.","family":"Vagenakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros","family":"Tsoutsinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicia","family":"Kakava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyridon","family":"Rammos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,18]]},"reference":[{"key":"1897_CR1","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.healun.2017.07.018","volume":"36","author":"JW Rossano","year":"2017","unstructured":"Rossano JW, Cherikh WS, Chambers DC, Goldfarb S, Khush K, Kucheryavaya AY et al (2017) The registry of the international society for heart and lung transplantation: twentieth pediatric heart transplantation report-2017; focus theme: Allograft ischemic time. J Heart Lung Transplant 36:1060\u20131069","journal-title":"J Heart Lung Transplant"},{"key":"1897_CR2","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1161\/CIRCULATIONAHA.112.000685","volume":"127","author":"CS Almond","year":"2013","unstructured":"Almond CS, Morales DL, Blackstone EH, Turrentine MW, Imamura M, Massicotte MP et al (2013) Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children. Circulation 127:1702\u20131711","journal-title":"Circulation"},{"key":"1897_CR3","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1161\/CIRCULATIONAHA.106.180449","volume":"115","author":"CE Canter","year":"2007","unstructured":"Canter CE, Shaddy RE, Bernstein D, Hsu DT, Chrisant MR, Kirklin JK et al (2007) Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on cardiovascular disease in the young; the councils on clinical cardiology, cardiovascular nursing, and cardiovascular surgery and anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 115:658\u2013676","journal-title":"Circulation"},{"key":"1897_CR4","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1017\/S1047951104005049","volume":"14","author":"RF English","year":"2004","unstructured":"English RF, Janosky JE, Ettedgui JA, Webber SA (2004) Outcomes for children with acute myocarditis. Cardiol Young 14: 488\u2013493","journal-title":"Cardiol Young"},{"key":"1897_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.healun.2007.02.004","volume":"26","author":"AM Berg","year":"2007","unstructured":"Berg AM, Snell L, Mahle WT (2007) Home inotropic therapy in children. J Heart Lung Transplant 26:453\u2013457","journal-title":"J Heart Lung Transplant"},{"key":"1897_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cardfail.2005.11.001","volume":"12","author":"JF Price","year":"2006","unstructured":"Price JF, Towbin JA, Dreyer WJ, Moffett BS, Kertesz NJ, Clunie SK et al (2006) Outpatient continuous parenteral inotropic therapy as bridge to transplantation in children with advanced heart failure. J Card Fail 12:139\u2013143","journal-title":"J Card Fail"},{"key":"1897_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1161\/CIRCHEARTFAILURE.114.001528","volume":"8","author":"BF Birnbaum","year":"2015","unstructured":"Birnbaum BF, Simpson KE, Boschert TA, Zheng J, Wallendorf MJ, Schechtman K et al (2015) Intravenous home inotropic use is safe in pediatric patients awaiting transplantation. Circ Heart Fail 8:64\u201370","journal-title":"Circ Heart Fail"},{"key":"1897_CR8","doi-asserted-by":"publisher","first-page":"e283-352","DOI":"10.1161\/CIR.0b013e318276ce9b","volume":"127","author":"AE Epstein","year":"2013","unstructured":"Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS et al (2013) 2012 ACCF\/AHA\/HRS focused update incorporated into the ACCF\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 127:e283-352","journal-title":"Circulation"},{"key":"1897_CR9","doi-asserted-by":"publisher","first-page":"e147-239","DOI":"10.1016\/j.jacc.2013.05.020","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH et al (2013) 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62:e147-239","journal-title":"J Am Coll Cardiol"},{"key":"1897_CR10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1161\/CIRCHEARTFAILURE.108.839076","volume":"2","author":"EZ Gorodeski","year":"2009","unstructured":"Gorodeski EZ, Chu EC, Reese JR, Shishehbor MH, Hsich E, Starling RC (2009) Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure. Circ Heart Fail 2:320\u2013324","journal-title":"Circ Heart Fail"},{"key":"1897_CR11","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1056\/NEJM199812173392503","volume":"339","author":"JN Cohn","year":"1998","unstructured":"Cohn JN, Goldstein SO, Greenberg BH, Lorell BH, Bourge RC, Jaski BE et al (1998) A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators. N Engl J Med 339:1810\u20131816","journal-title":"N Engl J Med"},{"key":"1897_CR12","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(96)10488-8","volume":"349","author":"JR Hampton","year":"1997","unstructured":"Hampton JR, van Veldhuisen DJ, Kleber FX, Cowley AJ, Ardia A, Block P et al (1997) Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators. Lancet 349:971\u2013977","journal-title":"Lancet"},{"key":"1897_CR13","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","volume":"325","author":"M Packer","year":"1991","unstructured":"Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM et al (1991) Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 325:1468\u20131475","journal-title":"N Engl J Med"},{"key":"1897_CR14","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1093\/eurheartj\/ehp338","volume":"30","author":"M Metra","year":"2009","unstructured":"Metra M, Eichhorn E, Abraham WT, Linseman J, Bohm M, Corbalan R et al (2009) Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials. Eur Heart J 30:3015\u20133026","journal-title":"Eur Heart J"},{"key":"1897_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1161\/CIRCHEARTFAILURE.111.963991","volume":"5","author":"SJ Park","year":"2012","unstructured":"Park SJ, Milano CA, Tatooles AJ, Rogers JG, Adamson RM, Steidley DE et al (2012) Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail 5:241\u2013248","journal-title":"Circ Heart Fail"},{"key":"1897_CR16","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/eurheartj\/ehi875","volume":"27","author":"L Luca De","year":"2006","unstructured":"De Luca L, Colucci WS, Nieminen MS, Massie BM, Gheorghiade M (2006) Evidence-based use of levosimendan in different clinical settings. Eur Heart J 27:1908\u20131920","journal-title":"Eur Heart J"},{"key":"1897_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2165\/00003088-200746070-00001","volume":"46","author":"S Antila","year":"2007","unstructured":"Antila S, Sundberg S, Lehtonen LA (2007) Clinical pharmacology of levosimendan. Clin Pharmacokinet 46:535\u2013552","journal-title":"Clin Pharmacokinet"},{"key":"1897_CR18","first-page":"227","volume":"5","author":"MS Nieminen","year":"2013","unstructured":"Nieminen MS, Fruhwald S, Heunks LM, Suominen PK, Gordon AC, Kivikko M et al (2013) Levosimendan: current data, clinical use and future development. Heart Lung Vessel 5:227\u2013245","journal-title":"Heart Lung Vessel"},{"key":"1897_CR19","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/icvts\/ivt297","volume":"17","author":"U Angadi","year":"2013","unstructured":"Angadi U, Westrope C, Chowdhry MF (2013) Is levosimendan effective in paediatric heart failure and post-cardiac surgeries? Interact Cardiovasc Thorac Surg 17:710\u2013714","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"1897_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2253-11-18","volume":"11","author":"PK Suominen","year":"2011","unstructured":"Suominen PK (2011) Single-center experience with levosimendan in children undergoing cardiac surgery and in children with decompensated heart failure. BMC Anesthesiol 11:18","journal-title":"BMC Anesthesiol"},{"key":"1897_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/2150135116674466","volume":"8","author":"P Suominen","year":"2017","unstructured":"Suominen P, Mattila N, Nyblom O, Rautiainen P, Turanlahti M, Rahkonen O (2017) The hemodynamic effects and safety of repetitive Levosimendan infusions on children with dilated cardiomyopathy. World J Pediatr Congenit Heart Surg 8:25\u201331","journal-title":"World J Pediatr Congenit Heart Surg"},{"key":"1897_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.healun.2007.02.005","volume":"26","author":"EK Rhee","year":"2007","unstructured":"Rhee EK, Canter CE, Basile S, Webber SA, Naftel DC (2007) Sudden death prior to pediatric heart transplantation: would implantable defibrillators improve outcome? J Heart Lung Transplant 26:447\u2013452","journal-title":"J Heart Lung Transplant"},{"key":"1897_CR23","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1001\/jama.298.10.1171","volume":"298","author":"RE Shaddy","year":"2007","unstructured":"Shaddy RE, Boucek MM, Hsu DT, Boucek RJ, Canter CE, Mahony L et al (2007) Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA 298:1171\u20131179","journal-title":"JAMA"},{"key":"1897_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/archdischild-2014-308080","volume":"101","author":"TV Vigneswaran","year":"2016","unstructured":"Vigneswaran TV, Brown JR, Breuer J, Burch M (2016) Parvovirus B19 myocarditis in children: an observational study. Arch Dis Child 101:177\u2013180","journal-title":"Arch Dis Child"},{"key":"1897_CR25","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/ejcts\/ezu544","volume":"48","author":"F Rita De","year":"2015","unstructured":"De Rita F, Hasan A, Haynes S, Peng E, Gandolfo F, Ferguson L et al (2015) Outcome of mechanical cardiac support in children using more than one modality as a bridge to heart transplantation. Eur J Cardiothorac Surg 48:917\u2013922 (discussion 22)","journal-title":"Eur J Cardiothorac Surg"},{"key":"1897_CR26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/ejcts\/ezt246","volume":"44","author":"JK Kirklin","year":"2013","unstructured":"Kirklin JK (2013) Long-term mechanical circulatory support: could it really have a public health impact? Eur J Cardiothorac Surg 44:198\u2013200","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-018-1897-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-018-1897-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-018-1897-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T07:16:37Z","timestamp":1560842197000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-018-1897-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,18]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1897"],"URL":"https:\/\/doi.org\/10.1007\/s00246-018-1897-5","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,18]]},"assertion":[{"value":"20 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with animals performed by any of the authors. All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}